Literature DB >> 33479893

Purification of Murine and Human IL-10-Producing B Cells from Different Anatomical Compartments.

Francesca Mion1, Eleonora Martinis2, Carlo E M Pucillo2, Silvia Tonon2.   

Abstract

IL-10 is the best known and most studied anti-inflammatory cytokine and, in the last 20 years, it has acquired even greater fame as it has been associated with the regulatory phenotype of B cells. Indeed, although great efforts have been made to find a unique marker, to date IL-10 remains the main way to follow both murine and human regulatory B cells, hence the need of precise and reproducible methods to identify and purify IL-10-producing B cells for both functional and molecular downstream assays. In this chapter, we present our protocols to isolate these cells from the murine spleen and peritoneum and from human peripheral blood. Since the production of IL-10 by B cells is not only a weapon to counteract the adverse effect of pro-inflammatory cytokines but also a response to cellular activation, we focused on those B cells that are prone to IL-10 production and detectable following a short-term stimulation with phorbol-12-myristate-13-acetate, ionomycin, and lipopolysaccharide (murine system) or CpG (human system).

Entities:  

Keywords:  B cells; Blood; IL-10; Peritoneum; Spleen

Mesh:

Substances:

Year:  2021        PMID: 33479893     DOI: 10.1007/978-1-0716-1237-8_4

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  12 in total

Review 1.  Signals controlling the development and activity of regulatory B-lineage cells.

Authors:  Yoshihiro Baba; Masanori Matsumoto; Tomohiro Kurosaki
Journal:  Int Immunol       Date:  2015-05-08       Impact factor: 4.823

Review 2.  Cytokine reporter mice: the special case of IL-10.

Authors:  H Bouabe
Journal:  Scand J Immunol       Date:  2012-06       Impact factor: 3.487

Review 3.  Role of interleukin 10 transcriptional regulation in inflammation and autoimmune disease.

Authors:  Shankar Subramanian Iyer; Gehong Cheng
Journal:  Crit Rev Immunol       Date:  2012       Impact factor: 2.214

4.  IL-10-producing B cells are characterized by a specific methylation signature.

Authors:  Silvia Tonon; Francesca Mion; Jun Dong; Hyun-Dong Chang; Emiliano Dalla; Patrizia Scapini; Giuseppe Perruolo; Andrea Zanello; Matteo Dugo; Marco A Cassatella; Mario P Colombo; Andreas Radbruch; Claudio Tripodo; Carlo E Pucillo
Journal:  Eur J Immunol       Date:  2019-05-07       Impact factor: 5.532

Review 5.  Human regulatory B cells in health and disease: therapeutic potential.

Authors:  Claudia Mauri; Madhvi Menon
Journal:  J Clin Invest       Date:  2017-03-01       Impact factor: 14.808

6.  Expression of interleukin-10 in intestinal lymphocytes detected by an interleukin-10 reporter knockin tiger mouse.

Authors:  Masahito Kamanaka; Sean T Kim; Yisong Y Wan; Fayyaz S Sutterwala; Maria Lara-Tejero; Jorge E Galán; Ed Harhaj; Richard A Flavell
Journal:  Immunity       Date:  2006-11-30       Impact factor: 31.745

7.  Ly-1 B (B-1) cells are the main source of B cell-derived interleukin 10.

Authors:  A O'Garra; R Chang; N Go; R Hastings; G Haughton; M Howard
Journal:  Eur J Immunol       Date:  1992-03       Impact factor: 5.532

8.  A regulatory B cell subset with a unique CD1dhiCD5+ phenotype controls T cell-dependent inflammatory responses.

Authors:  Koichi Yanaba; Jean-David Bouaziz; Karen M Haas; Jonathan C Poe; Manabu Fujimoto; Thomas F Tedder
Journal:  Immunity       Date:  2008-05       Impact factor: 31.745

Review 9.  Regulatory B cells: the cutting edge of immune tolerance in kidney transplantation.

Authors:  Bo Peng; Yingzi Ming; Cheng Yang
Journal:  Cell Death Dis       Date:  2018-01-25       Impact factor: 8.469

10.  In vitro-Induced Human IL-10+ B Cells Do Not Show a Subset-Defining Marker Signature and Plastically Co-express IL-10 With Pro-Inflammatory Cytokines.

Authors:  Laura C Lighaam; Peter-Paul A Unger; David W Vredevoogd; Dorit Verhoeven; Ellen Vermeulen; Annelies W Turksma; Anja Ten Brinke; Theo Rispens; S Marieke van Ham
Journal:  Front Immunol       Date:  2018-09-05       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.